45 related articles for article (PubMed ID: 16634759)
1. P2X1 stimulation promotes thrombin receptor-mediated platelet aggregation.
Erhardt JA; Toomey JR; Douglas SA; Johns DG
J Thromb Haemost; 2006 Apr; 4(4):882-90. PubMed ID: 16634759
[TBL] [Abstract][Full Text] [Related]
2. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.
Holinstat M; Voss B; Bilodeau ML; McLaughlin JN; Cleator J; Hamm HE
J Biol Chem; 2006 Sep; 281(36):26665-74. PubMed ID: 16837456
[TBL] [Abstract][Full Text] [Related]
3. A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity.
Han X; Knauss EA; Fuente M; Li W; Conlon RA; LePage DF; Jiang W; Renna SA; McKenzie SE; Nieman MT
J Thromb Haemost; 2024 Jun; 22(6):1715-1726. PubMed ID: 38508397
[TBL] [Abstract][Full Text] [Related]
4. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.
Ma L; Perini R; McKnight W; Dicay M; Klein A; Hollenberg MD; Wallace JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):216-20. PubMed ID: 15615851
[TBL] [Abstract][Full Text] [Related]
5. Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race.
Edelstein LC; Simon LM; Lindsay CR; Kong X; Teruel-Montoya R; Tourdot BE; Chen ES; Ma L; Coughlin S; Nieman M; Holinstat M; Shaw CA; Bray PF
Blood; 2014 Nov; 124(23):3450-8. PubMed ID: 25293779
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 7, 4'-dimethoxy-3-hydroxyflavone as a protease-activated receptor 4 antagonist with antithrombotic activity and less bleeding tendency in mice.
Lin YT; Li Y; Hsu HC; Tsai JY; Lee JH; Tai CJ; Wu MJ; Wu CC
Biochem Pharmacol; 2022 Aug; 202():115152. PubMed ID: 35752281
[TBL] [Abstract][Full Text] [Related]
7. Identification of the minimum PAR4 inhibitor pharmacophore and optimization of a series of 2-methoxy-6-arylimidazo[2,1-b][1,3,4]thiadiazoles.
Temple KJ; Duvernay MT; Maeng JG; Blobaum AL; Stauffer SR; Hamm HE; Lindsley CW
Bioorg Med Chem Lett; 2016 Nov; 26(22):5481-5486. PubMed ID: 27777004
[TBL] [Abstract][Full Text] [Related]
8. The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes.
Denorme F; Armstrong ND; Stoller ML; Portier I; Tugolukova EA; Tanner RM; Montenont E; Bhatlekar S; Cody M; Rustad JL; Ajanel A; Tolley ND; Murray DC; Boyle JL; Nieman MT; McKenzie SE; Yost CC; Lange LA; Cushman M; Irvin MR; Bray PF; Campbell RA
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37471144
[TBL] [Abstract][Full Text] [Related]
9. Loss of zinc transporters ZIP1 and ZIP3 augments platelet reactivity in response to thrombin and accelerates thrombus formation
Elgheznawy A; Öftering P; Englert M; Mott K; Kaiser F; Kusch C; Gbureck U; Bösl MR; Schulze H; Nieswandt B; Vögtle T; Hermanns HM
Front Immunol; 2023; 14():1197894. PubMed ID: 37359521
[TBL] [Abstract][Full Text] [Related]
10. Reversible Platelet Integrin αIIbβ3 Activation and Thrombus Instability.
Zou J; Swieringa F; de Laat B; de Groot PG; Roest M; Heemskerk JWM
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293367
[TBL] [Abstract][Full Text] [Related]
11. How Fungal Glycans Modulate Platelet Activation via Toll-Like Receptors Contributing to the Escape of
Jawhara S
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32645848
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Imaging of Venous Thrombus and Pulmonary Embolism Using Novel Murine Venous Thromboembolism Model.
Okano M; Hara T; Nishimori M; Irino Y; Satomi-Kobayashi S; Shinohara M; Toh R; Jaffer FA; Ishida T; Hirata KI
JACC Basic Transl Sci; 2020 Apr; 5(4):344-356. PubMed ID: 32368694
[TBL] [Abstract][Full Text] [Related]
13. Mouse laser injury models: variations on a theme.
Stalker TJ
Platelets; 2020 May; 31(4):423-431. PubMed ID: 32297542
[TBL] [Abstract][Full Text] [Related]
14. P2X1 Receptors Amplify FcγRIIa-Induced Ca2+ Increases and Functional Responses in Human Platelets.
Ilkan Z; Watson S; Watson SP; Mahaut-Smith MP
Thromb Haemost; 2018 Feb; 118(2):369-380. PubMed ID: 29443373
[TBL] [Abstract][Full Text] [Related]
15. Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity.
Koupenova M; Ravid K
Front Pharmacol; 2018; 9():37. PubMed ID: 29441021
[TBL] [Abstract][Full Text] [Related]
16. The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors.
Cognasse F; Nguyen KA; Damien P; McNicol A; Pozzetto B; Hamzeh-Cognasse H; Garraud O
Front Immunol; 2015; 6():83. PubMed ID: 25784910
[TBL] [Abstract][Full Text] [Related]
17. Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles.
Rothmeier AS; Marchese P; Petrich BG; Furlan-Freguia C; Ginsberg MH; Ruggeri ZM; Ruf W
J Clin Invest; 2015 Apr; 125(4):1471-84. PubMed ID: 25705884
[TBL] [Abstract][Full Text] [Related]
18. P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice.
Darbousset R; Delierneux C; Mezouar S; Hego A; Lecut C; Guillaumat I; Riederer MA; Evans RJ; Dignat-George F; Panicot-Dubois L; Oury C; Dubois C
Blood; 2014 Oct; 124(16):2575-85. PubMed ID: 25150292
[TBL] [Abstract][Full Text] [Related]
19. ATP antagonizes thrombin-induced signal transduction through 12(S)-HETE and cAMP.
Burzaco J; Conde M; Parada LA; Zugaza JL; Dehaye JP; Marino A
PLoS One; 2013; 8(6):e67117. PubMed ID: 23826207
[TBL] [Abstract][Full Text] [Related]
20. The P2X1 receptor and platelet function.
Mahaut-Smith MP; Jones S; Evans RJ
Purinergic Signal; 2011 Sep; 7(3):341-56. PubMed ID: 21484087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
